Tert-butyl 4-[4-(6-pyridin-4-yl-1H-benzimidazol-2-yl)-1,3-thiazol-2-yl]piperidine-1-carboxylate
C25H27N5O2S — CID 117075015
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl 4-[4-(6-pyridin-4-yl-1H-benzimidazol-2-yl)-1,3-thiazol-2-yl]piperidine-1-carboxylate
Tert-butyl 4-[4-(6-pyridin-4-yl-1H-benzimidazol-2-yl)-1,3-thiazol-2-yl]piperidine-1-carboxylate (PubChem CID 117075015) has the molecular formula C25H27N5O2S and a molecular weight of 461.59 g/mol. Its IUPAC name is tert-butyl 4-[4-(6-pyridin-4-yl-1H-benzimidazol-2-yl)-1,3-thiazol-2-yl]piperidine-1-carboxylate.
Molecular Properties
| Compound Name | Tert-butyl 4-[4-(6-pyridin-4-yl-1H-benzimidazol-2-yl)-1,3-thiazol-2-yl]piperidine-1-carboxylate |
|---|---|
| PubChem CID | 117075015 |
| Molecular Formula | C25H27N5O2S |
| Molecular Weight | 461.59 g/mol |
| Exact Mass | 461.19 |
| IUPAC Name | tert-butyl 4-[4-(6-pyridin-4-yl-1H-benzimidazol-2-yl)-1,3-thiazol-2-yl]piperidine-1-carboxylate |
| SMILES | CC(C)(C)OC(=O)N1CCC(c2nc(-c3nc4ccc(-c5ccncc5)cc4[nH]3)cs2)CC1 |
| InChI | InChI=1S/C25H27N5O2S/c1-25(2,3)32-24(31)30-12-8-17(9-13-30)23-29-21(15-33-23)22-27-19-5-4-18(14-20(19)28-22)16-6-10-26-11-7-16/h4-7,10-11,14-15,17H,8-9,12-13H2,1-3H3,(H,27,28) |
| InChIKey | ZUXPMUMVDSNXDD-UHFFFAOYSA-N |
| XLogP | 5.86 |
| TPSA | 84.00 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 461.59 |
| LogP ≤ 5 | 5.86 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 117075015 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.